Glucagon-like peptide-1 relaxes gastric antrum through nitric oxide in mice

Peptides

Volumn 32, Issue 1, 2011, Pages 60-64

  Rotondo, Alessandra ^a   Amato, Antonella ^a   Lentini, Laura ^a   Baldassano, Sara ^a   Mul, Flavia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Gastric motility; Gastrointestinal hormones; Glucagon like peptide 1; Nitric oxide

Indexed keywords

CARBACHOL; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TETRODOTOXIN;

ANIMAL EXPERIMENT; ARTICLE; FEEDING BEHAVIOR; GASTROINTESTINAL MOTILITY; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH ANTRUM; STOMACH FUNDUS;

ANIMALS; GASTROINTESTINAL MOTILITY; GLUCAGON-LIKE PEPTIDE 1; MICE; NITRIC OXIDE; PYLORIC ANTRUM; RECEPTORS, GLUCAGON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS;

EID: 78650520425     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.09.028     Document Type: Article

References (42)

1. A. Amato, L. Cinci, A. Rotondo, R. Serio, M.S. Faussone-Pellegrini, and M.G. Vannucchi Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors Neurogastroenterol Motil 22 2010 664 672
2. C.N. Andrews, A.E. Bharucha, M. Camilleri, P.A. Low, B.M. Seide, and D.D. Burton Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults Am J Physiol Gastrointest Liver Physiol 292 2007 G1359 G1365
3. C.N. Andrews, A.E. Bharucha, M. Camilleri, P.A. Low, B.M. Seide, and D.D. Burton Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans Neurogastroenterol Motil 19 2007 716 723
4. M. Anvari, C.A. Paterson, E.E. Daniel, and T.J. Mcdonald Effects of GLP-1 on gastric emptying, antropyloric motility, and transpyloric flow in response to a nonnutrient liquid Dig Dis Sci 43 1998 1133 1140
5. L.L. Baggio, and D.J. Drucker Biology of incretins: GLP-1 and GIP Gastroenterology 132 2007 2131 2157
6. V. Bucinskate, T. Tolessa, J. Pedersen, B. Rydqvist, L. Zerihun, and J.J. Holst Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat Neurogastroenterol Motil 21 2009 978 1078
7. B.P. Bullock, R.S. Heller, and J.F. Habener Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor Endocrinology 137 1996 2968 2978
8. R.V. Campos, Y.C. Lee, and D.J. Drucker Divergent tissue-specific and developmental expression of receptors from glucagon and glucagon-like peptide-1 in the mouse Endocrinology 134 1994 2156 2164
9. E.E. Daniel, M. Anvari, J.E.T. Fox-Threlkeld, and T.J. McDonald Local, exendin-(9-39)-insensitive, site of action of GLP-1 in canine ileum Am J Physiol Gastrointest Liver Physiol 283 2002 G595 G602
10. A.M. Deane, N.Q. Nguyen, J.E. Stevens, R.J.L. Fraser, R.H. Holloway, and L.K. Besanko Endogenous glucagons-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia J Clin Endocrinol Metabol 95 2010 215 221
11. S. Delgado-Arros, D.Y. Kim, D.D. Burton, G.M. Thomforde, D. Stephens, and B.H. Brinkmann Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans Am J Physiol Gastrointest Liver Physiol 282 2002 G424 G431
12. J.L. Dunphy, R.G. Taylor, and P.J. Fuller Tissue distribution of rat glucagons receptor and GLP-1 receptor gene expression Mol Cell Endocrinol 141 2008 179 186
13. H.C. Fehmann, and J.F. Habener Insulinotrophic hormone glucagons-like peptide-1 (7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma βTC-1 cells Endocrinology 130 1992 156 166
14. A. Flint, A. Raben, A. Astrup, and J.J. Holst Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans J Clin Invest 101 1998 515 520
15. M. Giralt, and P. Vergara Glucagonlike Peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat Dig Dis Sci 44 1999 322 329
16. B. Göke, P.J. Larsen, J.D. Mikkelsen, and S.P. Sheikh Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites Eur J Neurosci 7 1995 2294 2300
17. M.A. Gülpinar, A. Bozkurt, T. Cokun, N.B. Ulusoy, and B.C. Yegen Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats Am J Physiol Gastrointest Liver Physiol 278 2000 G924 G929
18. J.P. Gutzwiller, B. Göke, J. Drewe, P. Hildebrand, S. Ketterer, and D. Handschin Glucagon-like peptide-1: a potent regulator of food intake in humans Gut 44 1999 81 86
19. J.J. Holst The physiology of glucagon-like peptide 1 Physiol Rev 87 2007 1409 1439
20. N. Imeryüz, B.C. Yeen, A. Bozkurt, T. Cokun, M.L. Villanueva-Peñacarrillo, and N.B. Ulusoy Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms Am J Physiol Gastrointest Liver Physiol 273 1997 G920 G927
21. K.G. Kumar, L.O. Byerley, J. Volaufova, D.J. Drucker, G.A. Churchill, and R. Li Genetic variation in Glp1r expression influences the rate of gastric emptying in mice Am J Physiol Regul Integr Comp Physiol 294 2008 R362 R371
22. P.J. Larsen, C. Fledelius, L.B. Knudsen, and M. Tang-Christensen Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats Diabetes 50 2001 2530 2539 (Pubitemid 33642771)
23. T.J. Little, A.N. Pilichiewicz, A. Russo, L. Phillips, K.L. Jones, and M.A. Nauck Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses J Clin Endocrinol Metab 91 2006 1916 1923
24. J.J. Meier, B. Gallwitz, S. Salmen, O. Goetze, J.J. Holst, and W.F. Schmidt Normalization of glucose concentration and deceleration of gastric emptying after solid meals during intravenous glucagons-like peptide 1 in patients with type 2 diabetes J Clin Endocrinol Metab 88 2003 2719 2725
25. T. Miki, K. Minami, H. Shinozaki, K. Matsumura, A. Saraya, and H. Ikeda Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility Diabetes 54 2005 1056 1063
26. F. Mul, and R. Serio NANC inhibitory neurotransmission in mouse isolated stomach: involvement of nitric oxide, ATP and vasoactive intestinal polypeptide Br J Pharmacol 140 2003 431 437
27. A. Nakagawa, H. Satake, H. Nakabayashi, M. Nishizawa, K. Furuya, and S. Nakano Receptor gene expression of glucagon-like peptide-1, but not glucose dependent insulinotropic polypeptide, in rat nodose ganglion cells Auton Neurosci 110 2004 36 43
28. E. Näslund, J. Bogefirs, P. Gryback, P. Bjellerup, H. Jacobsson, and J.J. Holst GLP-1 inhibits gastric emptying of water but does not influence plasma vasopressin, sodium or osmolarity Scand J Gastroent 2 2001 156 162
29. E. Näslund, S. Skogar, S. Efendic, and P.M. Hellström Glucagon-like peptide-1 analogue LY315902: effect on intestinal motility and release of insulin and somatostin Regul Pept 106 2002 89 95
30. J. Schirra, P. Houck, U. Wank, R. Arnold, B. Goke, and M. Katschinski Effects of glucagon-like peptide-1 (7-36) amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans Gut 46 2000 622 631
31. J. Schirra, M. Katschinski, C. Weidmann, T. Schafer, U. Wank, and R. Arnold Gastric emptying and release of incretin hormones after glucose ingestion in humans J Clin Invest 97 1996 92 103
32. J. Shirra, M. Nicolaus, R. Rogger, M. Katschinski, M. Stoor, and H.J. Woerle Endogenous glucagon-like peptide1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans Gut 55 2006 243 251
33. J. Shirra, M. Nicolaus, H.J. Woerle, C. Struckmeir, M. Katschinski, and B. Göke GLP-1 regulates gastroduodenal motility involving cholinergic pathways Neurogastroenterol Motil 21 2009 609 618
34. J. Schirra, U. Wank, R. Arnold, B. Göke, and M. Katschinski Effects of glucagon-like peptide-1 (7-36) amide on motility and sensation of the proximal stomach in humans Gut 50 2002 341 348
35. J. Schmidtler, K. Dehene, H.D. Allesher, V. Schusdziarra, M. Classen, and J.J. Holst Rat parietal cell receptors for GLP-1 (7-36) amide: Northern blot, cross-linking, and radioligand binding Am J Physiol Gastrointest Liver Physiol 267 1994 G423 G432
36. E.M. Sinclair, and D.J. Drucker Proglucagon-derived peptides: mechanisms of action and therapeutic potential Physiology 20 2005 357 365
37. T. Tolessa, M. Gutniak, J.J. Holst, S. Efendic, and P.M. Hellström Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanisms Dig Dis Sci 43 1998 2284 2290
38. T. Tolessa, M. Gutniak, J.J. Holst, S. Efendic, and P.M. Hellström Inhibitory effect of glucagon-like peptide-1 on small bowel motility J Clin Invest 102 1998 764 774
39. D. Tornehave, P. Kristensen, J. Romer, L.B. Knudsen, and R.S. Heller Expression of the GLP-1 receptor in mouse, rat and human pancreas J Histochem Cytochem 56 2008 841 851
40. G. Van Dijk, and T.E. Thiele Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress Neuropeptides 33 1999 406 414
41. A. Wettergren, M. Wøjdemann, and J.J. Holst The inhibitory effect of glucagon-like peptide-1 (7-36) amide on antral motility is antagonized by its N-terminally truncated primary metabolite GLP-1 (9-36) amide Peptides 19 1998 877 882
42. A. Wettergren, M. Wøjdemann, and J.J. Holst Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow Am J Physiol Gastrointest Liver Physiol 275 1998 G984 G992